510(k) Report

510(k) · Cleared

Cleared

Thrombuster II Aspiration Catheter

K213166510(k) SpecialCleared Oct 26, 202128-day reviewClass II21 CFR 870.5150

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Kaneka Medical America, LLC · QEZ Aspiration Thrombectomy Catheter

Cleared on Oct 26, 2021 as substantially equivalent to K101839 (Kaneka Pharma America, LLC, 2010) after a 28-day review. Its family tree reaches back 1 generation to 2010.

Decided
Oct 26, 2021
Review
28 days
Class
Class II
Product code
QEZ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K101839 (2010). No later device cites it as a predicate yet.

K101839 · Kaneka Pharma America Xpress-Way RX · Kaneka Pharma America, LLC · 20102010201220142016201820202022
  1. Root · 1 generation backK101839 Kaneka Pharma America Xpress-Way RXKaneka Pharma America, LLC · 2010
  2. This deviceK213166 Thrombuster II Aspiration CatheterKaneka Medical America, LLC · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K101839Kaneka Pharma America Xpress-Way RXKaneka Pharma America, LLC2010—
0 (this device)K213166Thrombuster II Aspiration CatheterKaneka Medical America, LLC2021—
FIG. 1 — Lineage of K213166, 2010–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QEZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QEZ device

  1. #1 K253925 Aventus Thrombectomy Systemscore 17.9 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K101839Kaneka Pharma America Xpress-Way RX
Summary page 4
…uct code is QEZ] Class II Classification Panel Cardiovascular (74) Predicate Device:  Xpress-Way RX [K101839 (Kaneka Corporation)] Page 1 of 3 The predicate device have not bee…
Kaneka Pharma America, LLC2010—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All QEZ devices

QEZ Aspiration Thrombectomy Catheter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · QEZ

5in 2025

2007: 112008: 62009: 42010: 32011: 72012: 52013: 42014: 12016: 12017: 32018: 12019: 32020: 32021: 32022: 22023: 12024: 12025: 52026 (partial year): 6
2007high 11 (2007) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QEZ

108in 2025

2007: 79 days median2008: 72 days median2009: 83 days median2010: 33 days median2011: 118 days median2012: 90 days median2013: 144 days median2017: 112 days median2019: 94 days median2020: 120 days median2021: 53 days median2025: 108 days median2026 (partial year): 98 days median
2007high 144 (2013) · low 33 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QEZ

No recall names QEZ since 2007.

Adverse event reports per year · QEZ

21in 2025

2021: 22022: 182023: 142024: 172025: 21
2007high 21 (2025) · low 0 (2007)2025

MAUDE reports naming product code QEZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007117900
200867200
200948300
201033300
2011711800
201259000
2013414400
20141—00
20150—00
20161—00
2017311200
20181—00
201939400
2020312000
202135302
20222—018
20231—014
20241—017
20255108021
20266980—

What is it indicated for?

The Thrombuster II Aspiration Catheter is indicated for the removal of fresh, soft emboli and thrombi from vessels in the coronary and peripheral system. The Thrombuster II is not intended for use in the cerebral vasculature.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K213166: Thrombuster II Aspiration Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K213166

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026